The U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co’s immunotherapy drug Opdivo for patients…
Read MoreThe U.S. Food and Drug Administration on Friday expanded its approval of Bristol-Myers Squibb Co’s immunotherapy drug Opdivo for patients…
Read MoreMen with high levels of cardiorespiratory fitness appear to have a lower incidence of lung or colon cancer, a new…
Read More